BRAVE in MS - Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis
Toggle Navigation
  • Home
  • Organization
    • Members
    • Ordinaries
    • Founders
  • PROJECT
    • Summary
    • Objectives
    • Translational
    • Outreaching
  • News
    • Documents
    • Related articles
  • Contacts
    • Shared
  • Follow Us Follow Us

Partner 1, Gianvito Martino (P.I.), Paola Panina (P.M.) (Fondazione Centro San Raffaele, Milan, Italy)

Partner 2, Sergio Baranzini (Co. P.I.) (University of California San Francisco San Francisco, USA)

Partner 3, Maria Pia Abbracchio, Ivano Eberini (University of Milan), Cristina Agresti (ISS, Rome) Stefania Olla, (IRGB-CNR, Cagliari), (Italy)

Partner 4, Jack Antel (McGill University - Montreal Neurological Institute, Montreal, Canada)

Partner 5, Anne Baron Van Evercooren, Brahim Nait Oumesmar (Pierre Marie Curie University, Paris, France)

Partner 6,  Alberto Bresciani (IRBM- Neuroscience), Italy

Partner 7, Tanja Kuhlmann (Westfälische Wilhelms-Universit-ät Münster, Münster, Germany)

Partner 8, Frauke Zipp (Johannes Gutenberg University Medical Center Mainz, Germany) and  Noerbert Goebels ( University Hospital of Dusseldorf, Germany)

BRAVEinMS: the network

  • Sei qui:  
  • Home
  • Organization
  • Members

Torna su

© 2022 BRAVE in MS - Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis